BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group

FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain.  “PRIM Group in Spain serves as a perfect … Continue Reading

BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico

FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico.  It is expected … Continue Reading

BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements

February 28, 2022 07:00 ET | Source: BioElectronics Corporation FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE:  BioElectronics Corporation is pleased to announce that it has signed … Continue Reading

BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway

Jan 3, 2022 6:01:09 AMOTC Markets Group Inc. News Service — FREDERICK, MD, Jan. 03, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC and St. John’s LLC, both of which are controlled by Whelan family members, have agreed to forgo … Continue Reading

BioElectronics Corporation Reports Q3 Earnings

Nov. 16, 2021 7:00 AM ETBioElectronics Corporation (BIEL) Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (BIEL) (https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3rd quarter. Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended September 30, … Continue Reading

Press Release: BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com

BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com Frederick, MD, Oct. 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC: BIEL), a leader in the development and manufacturing of non-invasive electroceuticals, today announced that Sree Koneru, Ph.D., will present at the Pain Management Investor Forum to be … Continue Reading

BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021

BIEL +23.33%  Frederick, Maryland, Jan. 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to report that Q4 revenue for 2020 exceeded $519,000, representing an increase of 241% when compared to Q3 revenue in 2020 ($151,956). Correspondingly, Q4 2020 revenue represents an increase of 233% when compared to the cumulative revenue of … Continue Reading

BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market

BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market FREDERICK, MD, Dec. 15, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), (www.bielcorp.com) is pleased to announce that it has executed an OEM agreement with KT Health, LLC to bring its innovative pain management devices to encompass retail and e-commerce … Continue Reading

BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx — Drug-Free Pain Therapy Devices

Opens the Sales Market for 33+ Additional Countries FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices. The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue … Continue Reading